GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/14/2026 4:21:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $11,969,562 | EPS -$1.90 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/14/2026 4:12:10 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $11,969,562 | EPS -$1.90 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 7/16/2026 7:32:23 AM | View | Proxy | SEC | Y 2025 | ||||||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/7/2026 4:19:52 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $15,692,891 | EPS -$1.77 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/7/2026 1:42:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $15,692,891 | EPS -$1.77 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/26/2026 4:45:06 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $20,390,569 | EPS -$14.80 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/26/2026 9:35:59 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $20,390,569 | EPS $4.70 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/6/2025 4:45:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $6,423,664 | EPS -$6.71 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/6/2025 4:21:29 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $6,423,664 | EPS -$6.71 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/7/2025 5:02:28 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $8,912,589 | EPS -$6.28 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/7/2025 5:01:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $8,912,589 | EPS -$6.28 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 7/17/2025 4:01:25 PM | View | Proxy | SEC | Y 2024 | ||||||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/14/2025 4:51:25 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $12,955,153 | EPS -$6.50 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/13/2025 4:13:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $12,955,153 | EPS -$6.50 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/13/2025 4:43:53 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $15,709,338 | EPS -$1.91 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/13/2025 4:07:28 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $15,709,338 | EPS -$0.28 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/8/2024 4:06:57 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $11,389,153 | EPS -$0.47 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/8/2024 6:11:58 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $11,389,153 | EPS -$0.47 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 10/24/2024 6:16:37 AM | View | Proxy | SEC | Y 2023 | ||||||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/14/2024 6:01:47 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $14,054,619 | EPS -$0.39 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/8/2024 4:16:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $14,054,619 | EPS -$0.39 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/9/2024 4:26:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $16,123,210 | EPS -$38.73 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/9/2024 8:31:44 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $16,123,210 | EPS -$38.73 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/14/2024 4:59:15 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $12,169,229 | EPS -$9.64 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/13/2024 4:53:56 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $12,169,229 | EPS -$2.03 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 2/27/2024 6:07:58 AM | View | Proxy | SEC | Y 2023 | ||||||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/9/2023 5:28:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $15,067,857 | EPS -$1.95 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/9/2023 5:11:44 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $15,067,857 | EPS -$1.95 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 9/12/2023 6:05:31 AM | View | Proxy | SEC | Y 2022 | ||||||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/3/2023 2:27:33 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $16,709,444 | EPS -$2.13 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/2/2023 5:12:36 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $16,709,444 | EPS -$2.13 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/9/2023 3:12:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $18,450,726 | EPS -$4.09 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 5/8/2023 5:15:27 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $18,450,726 | EPS -$4.09 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/15/2023 2:48:00 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $14,458,063 | EPS -$46.81 | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 3/9/2023 6:05:48 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 11/10/2022 8:31:34 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 8/18/2022 7:01:43 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Quoin Pharmaceuticals, Ltd. (QNRX) | 4/14/2022 6:18:24 AM | Micro | View | Financials | 20-F | SEC | Y 2021 ending: 12/31/2021 | Assets $9,356,851 | EPS -$0.01 | ||
| Cellect Biotechnology Ltd. (QNRX) | 8/24/2021 4:17:04 PM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 3/29/2021 9:41:33 AM | Micro | View | Financials | 20-F | SEC | Y 2020 ending: 12/31/2020 | Assets $1,377,818 | EPS -$0.70 | ||
| Cellect Biotechnology Ltd. (QNRX) | 3/29/2021 9:30:28 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 11/20/2020 8:01:23 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 8/12/2020 8:03:06 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 5/21/2020 4:01:23 PM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 4/3/2020 8:12:52 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 4/3/2020 7:54:57 AM | Micro | View | Financials | 20-F | SEC | Y 2019 ending: 12/31/2019 | Assets $6,169,000 | EPS -$0.52 | ||
| Cellect Biotechnology Ltd. (QNRX) | 11/19/2019 7:13:03 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 8/13/2019 8:19:30 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 5/21/2019 7:14:22 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 3/18/2019 4:31:31 PM | Micro | View | Financials | 20-F | SEC | Y 2018 ending: 12/31/2018 | ||||
| Cellect Biotechnology Ltd. (QNRX) | 3/18/2019 4:27:20 PM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 11/13/2018 7:04:52 AM | View | Financials | Earnings | WIRE | Y 2022 | Assets $14,458,063 | EPS $8.98 | Export Earnings Model | ||
| Cellect Biotechnology Ltd. (QNRX) | 3/19/2018 4:30:59 PM | Micro | View | Financials | 20-F | SEC | Y 2017 ending: 12/31/2017 |